Age: 40.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Accidental exposure to product, Blister, Laceration, Polymerase chain reaction, Skin lesion
Clinical narrative: This spontaneous report as received from a pharmacist reporting about herself. On 08-SEP-2014 the pharmacist was administering a dose of ZOSTAVAX to a patient. A small amount of vaccine got on to pharmacist's hand. No adverse effects were reported. Product quality complaint was not involved. Action taken with ZOSTAVAX was unknown. The outcome of small amount of vaccine got on to pharmacist's hand was unknown. Additional information has been requested. Follow up information as received from a healthcare professional refers to a 40 year old female pharmacist who is the patient. Patient's concurrent conditions include allergy to carbamate products. Historical condition included case of chickenpox at the age of 5 or 6 years. On 08-SEP-2014 the pharmacist was administering a dose of ZOSTAVAX (dose: 0.65 ml, Lot # K000328, expiration date: 06-MAR-2015) to a patient. A small amount of vaccine got on to pharmacist's hand. A rash occurred at the site of exposure. The patient had 6 lesions scattered over the face. Scab was collected as a sample and in September 2014 the patient was diagnosed with chickenpox. Pharmacy manager reported that a pharmacist was administering ZOSTAVAX on 08-SEP-2014 and some of the vaccine leaked onto the pharmacist's left hand and fingers. The patient reported that she developed a lesion on her face on an unspecified date in September 2014. She visited her unspecified physician on 24-SEP-2014. The physician diagnosed the patient with a possible case of shingles. The patient then visited an unspecified Occupational Health Doctor on 25-SEP-2014. This physician diagnosed the patient with re-activation of chickenpox. He instructed the patient not to go back to work until the lesions have crusted over at which time she would no longer be contagious. The patient stated that she had another lesion appear 29-SEP-2014 on an unspecified area of her body and that it was itchy and she was still coming up with spots. Both unspecified physicians "did an unspecified culture on the lesions" on unspecified dates. No lab results have been provided. Additional information from case to be deleted included: Nurse stated that a pharmacist was administering ZOSTAVAX (lot#, expiry unknown, dose unspecified) on 08-SEP-2014 to an unspecified patient and the ZOSTAVAX accidentally "shot into the pharmacist's face". No concomitant medications were reported. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wildtype (WT) VZV strain or with the OKA/Merck vaccine strain. On 25-SEP-2014 at 09:30, the pharmacist, was going to be examined for a specimen collection of fluid-filled vesicles on her face. The Pharmacist was complaining that she developed blisters on her face on an unspecified date. The pharmacist was seen by her unspecified family doctor regarding the blisters on an unspecified date. The family doctor "did an unspecified culture on the blisters" on an unspecified date. No lab results have been provided. The nurse stated that the pharmacist was withdrawing the ZOSTAVAX vaccine from the vial before giving to the patient and the vaccine went onto her left hand not her face. The pharmacist developed small lacerations on her left hand not her face. The nurse also stated that the patient had additional vesicles on her face. The patient continues to have new breakout lesions. Unspecified where the new lesions are located. It was reported that the patient would be visiting the office for an appointment. No intervention to prevent serious criteria was done. There was no product quality complaint. The outcome of the events was reported as not recovered/not resolved. The causality of the events was not reported. On an unknown date the patient underwent a Polymerase Chain reaction analysis which revealed it was negative for both the wild type Varicella zoster and the Vaccine Strain virus. Additional information has been requested. It has been determined that case # 1409USA013212 is a duplicate of case # 1409USA004588. Therefore, case # 1409USA013212 is being deleted from our files and the cases consolidated into case 1409USA004588.